Woori group to acquire majority Sudo equity.

Published: 2004-03-18 06:57:00

Updated: 2004-03-18 06:57:00

Sudo pharmaceutical company announced on March 15 that the company issued 4 million stocks (5,600 won per a stock) to raise 22.4 billion won of new capitals by way of allocating all to the third party.

The third party included Mr. Kim Soo-kyeong, chairman of Woori hospital (1,050 thousand sto...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK